Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Author: John C. Goodman

The Worst of Obamacare

Posted on April 8, 2022 by John C. Goodman

Ever since Obamacare became law, my colleagues and I have been writing about a race to the bottom in the exchanges – where health plans try to attract the healthy and avoid the sick. The result: people with serious health problems are being denied access to the doctors and hospitals they desperately need.

+

Does Medicare Advantage Save the Government Money?

Posted on April 8, 2022April 10, 2022 by John C. Goodman

Matthew Holt at The Health Care Blog writes:

Critics (notably ex CMS veterans Berwick & Gilfillan) claim that risk adjustment games played by the private plans who run Medicare Advantage have cost up to $200bn over 10 years. Medpac (the independent body that advises Congress) estimates that “Medicare spends 4 percent more for MA enrollees than it would have spent if those enrollees remained in FFS Medicare” …. However data from the Medicare Trustees and other research from ACHP & the trade group Better Medicare Alliance suggests that Medpac’s analysis is incorrect and that Medicare Advantage saves the government about 9% per enrollee.

George Halvorson says the Medpac report is “fake news”.

+

Ivermectin

Posted on April 8, 2022April 8, 2022 by John C. Goodman

Scott Sumner on Ivermectin: https://www.econlib.org/trust-but-verify-2/

David Henderson on Ivermectin: https://www.econlib.org/ivermectin-and-statistical-significance/

Matt Yglesias on the real problem: No one has an incentive to do really thorough testing on generic drugs.

+

April 2022 Health Care News is now available

Posted on April 7, 2022 by John C. Goodman

April 2022 Health Care News is now available:

  • Congress Turns to the Think Tanks for Help
  • Democrats Go After Short Term Plans
  • California Punts on Single Payer Plan
  • Fauci’s Secret War on Great Barrington Declaration Authors
  • Insurers Ordered to Cover Sex Changes
  • Vaccine Skeptics Listed as “Terrorists”
  • Mark Cuban Launches Online, Low-Cost Generic Pharmacy
  • Military Data on Vaccine Adverse Effects Disappears
  • FDA Advisor: Agency is Ignoring Vaccine Side Effects
  • Sweden’s Approach to the Virus Wins Accolades
  • Johns Hopkins Study: Lockdowns Don’t Work
  • Goodman: Seniors Deserve an HSA
  • Blase: Subsidies Make Health Care Cost More
+
  • Previous
  • 1
  • …
  • 349
  • 350
  • 351
  • 352
  • 353
  • 354
  • 355
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 44 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom